Board of Directors and Senior Officers. (a) Each of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the Tidal Director Appointments, and subject to approval by the CSE and any other regulatory approvals, the board of directors shall consist of five (5) members of which two (2) members shall be nominees of Tidal and of which three (3) members shall by nominees of MichiCann, and the senior officers of the Resulting Issuer shall be appointed by the reconstituted board of Tidal following the Tidal Director Appointments.
(b) Each of the Parties hereby agree that their respective director nominees as set forth above shall satisfy the Resulting Issuer’s eligibility criteria of general application, including for the avoidance of doubt, applicable Laws and stock exchange rules or policies for director candidates (the “Director Eligibility Criteria”).
(c) Each of the Parties also hereby acknowledge that all directors and officers of the Resulting Issuer shall be required to complete applications for licensing in all jurisdictions where the Resulting Issuer or its subsidiaries operate or intend to conduct commercial cannabis operations and that such applications will require approvals by the applicable and relevant state regulatory bodies (the “State Licensing Approvals”). Any director or officer who fails to obtain the requisite State Licensing Approvals shall immediately be required to tender their resignation.
Board of Directors and Senior Officers. (a) Each of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the Tidal Director Appointments, and subject to approval by the CSE and any other regulatory approvals, the board of directors shall consist of six (6) members of which two (2) members shall be nominees of Tidal and of which four (4) members shall by nominees of MichiCann, and the senior officers of the Resulting Issuer shall be appointed by the reconstituted board of Tidal following the Tidal Director Appointments.
(b) Each of the Parties hereby agree that their respective director nominees as set forth above shall satisfy the Resulting Issuer's eligibility criteria of general application, including for the avoidance of doubt, applicable Laws and stock exchange rules or policies for director candidates (the “Director Eligibility Criteria”).
(c) Each of the Parties also hereby acknowledge that all directors and officers of the Resulting Issuer shall be required to complete applications for licensing in all jurisdictions where the Resulting Issuer or its subsidiaries operate or intend to conduct commercial cannabis operations and that such applications will require approvals by the applicable and relevant state regulatory bodies (the “State Licensing Approvals”). Any director or officer who fails to obtain the requisite State Licensing Approvals shall immediately be required to tender their resignation.
(d) Each of the Parties hereby agree that upon completion of the Business Combination: (i) the Resulting Issuer Board shall immediately appoint the Board Observer, (ii) that such Board Observer shall be nominated and recommended for election to the Resulting Issuer Board at the next meeting of shareholders of the Resulting Issuer, and (iii) that management of the Resulting Issuer shall endorse and recommend the Board Observer for election to long as such Board Observer meets the Director Eligibility Criteria and shall vote their Resulting Issuer Shares in respect of which management is granted a discretionary proxy in favour of the election of such Board Observer to the Resulting Issuer Board.
Board of Directors and Senior Officers. Each of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the Century Director Appointments, and subject to approval by the CSE, the board of directors and senior officers of Century shall consist of the following:
Board of Directors and Senior Officers. Each of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the Acquiror Director Appointments, and subject to approval by Cboe, the board of directors and senior officers of Acquiror shall be constituted as per Section 6.2(f).
Board of Directors and Senior Officers. Each of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the Director Appointments, and subject to compliance with applicable Securities Laws and the rules of the Nasdaq and the TSX, the board of directors and senior officers of Intercure shall consist of the following:
Board of Directors and Senior Officers. Each of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the Ultron Appointments, and subject to approval by the CSE, the board of directors and senior officers of the Resulting Issuer shall consist of the following: Name Title Xxxx Xxxxx Chief Executive Officer and Director Xxxx Xxxxxx Chief Financial Officer Xxxxx Xxxxxx Director Xxx Xxxx Director
Board of Directors and Senior Officers. Each of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the BeeImmune Appointment, and subject to approval by the CSE, the board of directors and senior officers of the Continuing Issuer shall consist of the following: Xxxx Xxxxx Chief Executive Officer and Director Xxxx Xx Chief Financial Officer and Corporate Secretary Xxxxx Xxxx President Xx. Xxxxxxx Xxxxx Chief Medical Officer Xxxxx Xxxx Vice President, Sales Xxxxxxx Xxxxxx Director Xxxxx Xxx Director
Board of Directors and Senior Officers. Each of the Parties hereby agrees that upon completion of the Business Combination and after giving effect to the CBD Director Appointments, and subject to approval by the CSE, the board of directors and senior officers of CBD shall consist of the following: Xxxxxxxx Xxxxx Director
Board of Directors and Senior Officers. Each of the Parties hereby agrees that upon completion of the Business Combination and giving effect to the Needle Director Appointments, and subject to approval by the TSXV, the board of directors of the Resulting Issuer shall consist of no fewer than five (5) and no more than (7) directors, all of which shall be nominated by Flowr, and the senior officers of the Resulting Issuer will be comprised of the existing senior officers of Flowr, as follows: • Xxxxxx Flow; • Xxxxx Xxxxxx; • Xxxx Xxxxx; • Xxxxx Xxxxxx; and • Xxxxx Xxxxx. • Xxxxxx Flow - President; • Xxxxx Xxxxx - Chief Executive Officer; • Xxxx Xxxx - Chief Financial Officer; • Xxxxx Xxxxxx - General Counsel; • Xxxx Xxxxx - Chief Policy and Medical Officer; • Xxxxx Xxxxxx - Corporate Secretary; • Xxxxx Xxxxx – Chief Strategy Officer; and • Xxxxx Xxxxxxx - Chief Operating Officer.
Board of Directors and Senior Officers. Each of the Parties hereby agrees that upon completion of the Business Combination and after giving effect to the I3 Director Appointments, and subject to approval by the CSE, the board of directors and senior officers of I3 shall consist of the following:
